For Immediate Release
Chicago, IL – March 7, 2019 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
Please use the Soundcloud link from this URL for the PR. Thanks: https://www.zacks.com/stock/news/357961/investing-in-the-innovation-winners
Investing in the Innovation Winners
Welcome to Episode #169 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
In this episode, Tracey is joined by Zacks Strategist David Bartosiak, who is also the Editor of Zacks Blockchain Innovators and Surprise Trader newsletters, to discuss companies that are innovating.
Innovation is often overlooked by investors. They like to invest in companies that already have the hot product.
But what if the hot product was already out there and is right under your nose?
Companies in the Innovation Game
Where can you find innovative companies? There’s no one definition but it’s pretty easy to find them is you just start paying attention. There’s a reason that everyone loves certain companies. They’re usually innovative.
But innovation isn’t always apparent. Is Tesla (TSLA - Free Report) really about AI or is creating an electric car for the masses going to be more innovative?
Apple has competition in its healthcare wearables push from companies like BioTelemetary (BEAT - Free Report) which just reported a record quarter thanks to its product line-up which includes a wireless glucose monitor.
Amazon (AMZN - Free Report) seemed innovative when it launched the AmazonGo stores. But is being able to grab a sandwich wrap faster than at the nearby sandwich shop really very innovative?
Booking (BKNG - Free Report) is taking on Airbnb and other home rental companies by launching alternative properties on its site. They now make up 20% of the company’s total revenue.
Nike (NKE - Free Report) is also not resting on its laurels. It has developed a self-lacing shoe and is moving further into wearables.
Where else can you find the innovation winners?
Tune into this week’s podcast to find out.
[In full disclosure, the author of this article owns shares of AMZN and BKNG in her personal portfolio.]
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.